Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan D Wickenden

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Neuropharmacology|December 31, 2002
Potassium channels as anti-epileptic drug targetsAlan D Wickenden
Current Protocols in Pharmacology|September 8, 2015
Overview of Electrophysiological TechniquesAlan D Wickenden
Nature Chemical Biology|February 17, 2009
Intracellular zinc irritates TRPA1Tue G Banke, Alan D Wickenden
Channels (Austin, Tex.)|January 11, 2021
Selective Targeting of Nav1.7 with Engineered Spider Venom-Based PeptidesRobert A Neff, Alan D Wickenden
Current Pharmaceutical Biotechnology|April 7, 2011
The physiology, pharmacology and future of P2X7 as an analgesic drug target: hype or promise?Anindya Bhattacharya, Robert A Neff, Alan D Wickenden
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 1, 2009
Sodium channel blockers for the treatment of neuropathic painAnindya Bhattacharya, Alan D Wickenden, Sandra R Chaplan
Current Protocols in Pharmacology|September 30, 2011
Electrophysiological analysis of heterologously expressed Kv and SK/IK potassium channelsNeil A Castle, Alan D Wickenden, Anruo Zou
Biochemical Pharmacology|February 20, 2017
Potentiating SLC transporter activity: Emerging drug discovery opportunitiesMarie-Laure Rives, Jonathan A Javitch, Alan D Wickenden
Neuroscience Letters|September 8, 2009
The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain siteKaren Padilla, Alan D Wickenden, Aaron C Gerlach, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 16, 2002
Myocardial infarction in rat eliminates regional heterogeneity of AP profiles, I(to) K(+) currents, and [Ca(2+)](i) transientsRoger Kaprielian, Rajan Sah, Tin Nguyen, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Neuropharmacology|December 31, 2002
Potassium channels as anti-epileptic drug targetsAlan D Wickenden
Current Protocols in Pharmacology|September 8, 2015
Overview of Electrophysiological TechniquesAlan D Wickenden
Nature Chemical Biology|February 17, 2009
Intracellular zinc irritates TRPA1Tue G Banke, Alan D Wickenden
Channels (Austin, Tex.)|January 11, 2021
Selective Targeting of Nav1.7 with Engineered Spider Venom-Based PeptidesRobert A Neff, Alan D Wickenden
Current Pharmaceutical Biotechnology|April 7, 2011
The physiology, pharmacology and future of P2X7 as an analgesic drug target: hype or promise?Anindya Bhattacharya, Robert A Neff, Alan D Wickenden
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 1, 2009
Sodium channel blockers for the treatment of neuropathic painAnindya Bhattacharya, Alan D Wickenden, Sandra R Chaplan
Current Protocols in Pharmacology|September 30, 2011
Electrophysiological analysis of heterologously expressed Kv and SK/IK potassium channelsNeil A Castle, Alan D Wickenden, Anruo Zou
Biochemical Pharmacology|February 20, 2017
Potentiating SLC transporter activity: Emerging drug discovery opportunitiesMarie-Laure Rives, Jonathan A Javitch, Alan D Wickenden
Neuroscience Letters|September 8, 2009
The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain siteKaren Padilla, Alan D Wickenden, Aaron C Gerlach, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 16, 2002
Myocardial infarction in rat eliminates regional heterogeneity of AP profiles, I(to) K(+) currents, and [Ca(2+)](i) transientsRoger Kaprielian, Rajan Sah, Tin Nguyen, et al.
Pageof 5